GO:0003755 peptidyl-prolyl cis-trans isomerase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0003755 describes the catalytic activity that interconverts the cis and trans conformations of peptide bonds preceding proline residues.
Peptidyl-prolyl cis-trans isomerases (PPIases) are classified into cyclophilins, FK506-binding proteins (FKBPs), and parvulins, with distinct inhibitor sensitivities.
PPIase activity is essential for protein folding, immune regulation, and cell signaling, and is implicated in cancer, neurodegeneration, and host-pathogen interactions [1,7].
Pin1, a parvulin-family PPIase, is a key regulator of cell cycle and aging, and is linked to Alzheimer disease and multiple cancers.
PPIase activity can be measured on the cell surface and correlates with extracellular matrix development.
CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of PPIase gene function in disease and development [5,8].

Description

Peptidyl-prolyl cis-trans isomerase (PPIase) activity, encoded by the Gene Ontology term GO:0003755, is a fundamental enzymatic function that catalyzes the rotation of the peptide bond preceding proline between its cis and trans conformations. This isomerization is often the rate-limiting step in protein folding, and PPIases are therefore critical for maintaining proteostasis and regulating protein function in all living organisms. The importance of this activity extends beyond basic protein folding: PPIases participate in immune responses, cell cycle control, and signal transduction, and their dysfunction is associated with cancer, neurodegeneration, and infectious diseases [1,7]. Researchers study PPIases to understand how conformational switches in proline-containing proteins drive physiological and pathological processes, and to develop therapeutic inhibitors [3,8]. The availability of CRISPR-based genetic models has further accelerated functional studies of PPIase genes in human cells and animal models.

peptidyl-prolyl cis-trans isomerase activity At A Glance

GO ID GO:0003755
GO term peptidyl-prolyl cis-trans isomerase activity
Ontology molecular_function
Synonym cyclophilin activity; rotamase activity; PPIase activity; immunophilin; parvulin
Major function Catalysis of the cis-trans isomerization of peptidyl-proline bonds
Definition Catalysis of the reaction: peptidyl-proline (omega=180) = peptidyl-proline (omega=0)
Related families Cyclophilins, FK506-binding proteins (FKBPs), parvulins
Inhibitors Cyclosporin A (cyclophilins), FK506 (FKBPs), juglone (parvulins)
Subcellular location Cytosol, nucleus, endoplasmic reticulum, mitochondria, cell surface

What Is GO:0003755?

GO:0003755 peptidyl-prolyl cis-trans isomerase activity is defined as the catalysis of the reaction: peptidyl-proline (omega=180) = peptidyl-proline (omega=0). In other words, it is the enzyme activity that accelerates the interconversion between the cis and trans isomers of the peptide bond that immediately precedes a proline residue in a polypeptide chain. This activity is also known as rotamase, cyclophilin, FK506-sensitive PPIase, parvulin, and immunophilin activity, reflecting the different protein families that possess it.

Why Is peptidyl-prolyl cis-trans isomerase activity Important in Cell Biology?

PPIase activity is essential for protein folding and function, and its dysregulation is linked to a wide range of human diseases, including cancer, Alzheimer disease, and infectious diseases [1,7]. Because proline isomerization is a slow step that can control protein activity, PPIases act as molecular switches in signaling pathways, making them attractive drug targets [3,8]. Understanding GO:0003755 is therefore critical for researchers in structural biology, chemical biology, and translational medicine.
PPIases catalyze a rate-limiting step in protein folding, influencing proteostasis.
Cyclophilins and FKBPs are targets of immunosuppressive drugs, linking PPIase activity to immune regulation.
Pin1 (a parvulin) regulates cell cycle and is implicated in cancer and Alzheimer disease.
PPIase activity on the cell surface correlates with extracellular matrix development.
PPIases are involved in host-pathogen interactions and are potential antimicrobial targets.
Small-molecule inhibitors of PPIases are being developed for cancer and other diseases [3,8].
PPIase activity can be measured using isomer-specific substrates and proteomics.
CRISPR screens can identify PPIase genes essential for cell fitness and drug response.

What Happens During peptidyl-prolyl cis-trans isomerase activity?

Substrate recognition and binding
In simple terms: The enzyme grabs a protein that has a proline residue and holds it in place.
PPIases recognize their substrates through a hydrophobic binding pocket that accommodates the proline ring and adjacent residues. Different families (cyclophilins, FKBPs, parvulins) have distinct substrate specificities, often determined by phosphorylation of residues near the proline.
Catalysis of cis-trans isomerization
In simple terms: The enzyme twists the peptide bond so it can flip between two shapes.
The catalytic mechanism involves distortion of the peptide bond and stabilization of the twisted transition state, lowering the energy barrier for rotation around the prolyl peptide bond. This allows the substrate to switch between cis and trans conformations, which can alter protein structure and function.
Release and downstream effects
In simple terms: Once the shape is changed, the protein is released and can do its job.
After isomerization, the substrate is released and may fold into its active conformation or interact with partners. This can affect signaling, transcription, and cell cycle progression. For example, Pin1-catalyzed isomerization of phospho-Thr-Pro motifs can regulate protein stability and activity.
Regulation by inhibitors and post-translational modifications
In simple terms: Other molecules can block or modify the enzyme to control its activity.
PPIase activity is regulated by endogenous inhibitors, phosphorylation, and redox state. Immunosuppressive drugs such as cyclosporin A and FK506 inhibit cyclophilins and FKBPs, respectively. Juglone inhibits parvulins, providing a tool to study Pin1 function.

Key Genes Involved in GO:0003755 peptidyl-prolyl cis-trans isomerase activity

The following genes encode proteins with peptidyl-prolyl cis-trans isomerase activity or are directly involved in its regulation.
GeneMajor RoleResearch Relevance
PPIACyclophilin A, cytosolic PPIaseTarget of cyclosporin A; involved in inflammation and cancer
PPIBCyclophilin B, ER PPIaseRequired for collagen folding; mutations cause osteogenesis imperfecta
PPICCyclophilin C, PPIaseExpressed in fibroblasts; role in extracellular matrix
PPIDCyclophilin D, mitochondrial PPIaseRegulates mitochondrial permeability transition
PPIECyclophilin E, nuclear PPIaseInvolved in pre-mRNA splicing
PPIFCyclophilin F, mitochondrial PPIaseModulates apoptosis and necrosis
PPIGCyclophilin G, nuclear PPIaseComponent of spliceosome
PPIHCyclophilin H, nuclear PPIasePart of U4/U6 snRNP
PPIL1Cyclophilin-like PPIaseComponent of spliceosome; mutations cause microcephaly
FKBP1AFKBP12, PPIaseTarget of FK506 and rapamycin; regulates mTOR
FKBP5FKBP51, PPIaseRegulates glucocorticoid receptor; implicated in depression
PIN1Parvulin PPIaseRegulates cell cycle; linked to cancer and Alzheimer disease
PIN4Parvulin PPIaseRole in pre-rRNA processing
NIMANever in mitosis A kinaseInteracts with Pin1; target in hepatocellular carcinoma
CYP1Cyclophilin in pathogensHost-pathogen interactions
MIPMacrophage infectivity potentiatorBacterial PPIase virulence factor
SlyDFKBP-type PPIase in E. coliModel for PPIase structure-function

How Is peptidyl-prolyl cis-trans isomerase activity Regulated?

PPIase activity is regulated at multiple levels. Transcriptionally, expression of cyclophilins and FKBPs is induced by stress, growth factors, and immune signals. Post-translationally, phosphorylation of PPIases such as Pin1 can modulate substrate specificity and catalytic activity. Endogenous inhibitors and redox modifications also control PPIase function. In addition, the mTOR pathway regulates FKBP12 and its interactions, linking PPIase activity to cell growth.

peptidyl-prolyl cis-trans isomerase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
PIN1Cancer, Alzheimer diseaseKnockout and point-mutation cell lines; mouse models
PPIAInflammation, cancerOverexpression and knockout in cancer cell lines
PPIBOsteogenesis imperfectaPatient-derived fibroblasts; knock-in mouse models
FKBP5Depression, stress responseKnockout mice; neuronal cell lines
MIPLegionella infectionBacterial knockout; host cell infection models
Cancer
PPIases are frequently overexpressed in cancers and contribute to tumor progression. Pin1 is overexpressed in many cancers and regulates oncogenes and tumor suppressors. NIMA-interacting 1 (Pin1) has been proposed as a therapeutic target in hepatocellular carcinoma. Cyclophilin A promotes cancer cell proliferation and metastasis.
Neurodegeneration
Pin1 is implicated in Alzheimer disease, where it regulates tau phosphorylation and amyloid precursor protein processing. Dysregulation of Pin1 leads to tau hyperphosphorylation and neurofibrillary tangle formation.
Infectious diseases
Pathogen PPIases, such as MIP in Legionella and cyclophilins in parasites, are virulence factors that modulate host immune responses. Targeting these PPIases is a potential antimicrobial strategy.
Genetic disorders
Mutations in PPIB cause osteogenesis imperfecta, and mutations in PPIL1 are associated with microcephaly, highlighting the importance of PPIases in development.

From peptidyl-prolyl cis-trans isomerase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the effect of PPIase gene knockout on cell viability?CRISPR knockout in cancer cell lines
How does a point mutation in the catalytic site affect isomerase activity?CRISPR point mutation (e.g., Pin1 active-site mutant)
Does a disease-associated mutation alter protein function?Knock-in of mutant allele in isogenic cell lines
Where does the PPIase localize in cells?Tagged knock-in with fluorescent protein
What happens when PPIase is overexpressed?CRISPR activation or cDNA overexpression
Which genes are essential in PPIase-dependent pathways?Genome-wide CRISPR library screening

How to Study the peptidyl-prolyl cis-trans isomerase activity Process

MethodWhat It MeasuresTypical Application
PPIase activity assayCatalytic rate of cis-trans isomerizationEnzyme kinetics and inhibitor testing
Cell surface PPIase assayExtracellular PPIase activityECM development studies
Co-immunoprecipitationProtein-protein interactionsIdentifying PPIase substrates
Phospho-peptide pull-downBinding to phosphorylated motifsPin1 substrate discovery
CRISPR knockout screenGene essentiality and fitnessIdentifying PPIase dependencies
RNA-seqTranscriptional changesPPIase-regulated gene expression
ProteomicsProtein abundance and modificationsGlobal effects of PPIase inhibition
Structural biology (X-ray/NMR)3D structure of PPIase-substrate complexesMechanistic studies
Enzymatic assays for PPIase activity
PPIase activity is typically measured using chromogenic or fluorogenic substrates that contain a proline residue, such as N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, in a coupled assay with chymotrypsin. This allows kinetic characterization of purified enzymes or cell lysates.
Cell surface PPIase activity
PPIase activity can be detected on the cell surface using specific substrates, and this activity correlates with extracellular matrix development. This method is useful for studying secreted or membrane-associated PPIases.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify PPIase substrates and interacting proteins. For example, Pin1 interactors have been mapped using phospho-peptide pull-downs.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify PPIase genes required for cell growth or drug sensitivity. These screens provide unbiased insights into PPIase function in health and disease.

How CRISPR Can Be Used to Study GO:0003755 peptidyl-prolyl cis-trans isomerase activity

Knockout

CRISPR knockout of PPIase genes (e.g., PPIA, PIN1) in cell lines can reveal their roles in proliferation, apoptosis, and stress responses. Knockout models are essential for validating drug targets and understanding loss-of-function phenotypes.

Point Mutation

Introducing point mutations in the catalytic domain of PPIases (e.g., Pin1 C113A) using CRISPR can dissect the contribution of isomerase activity versus other functions. Such models are valuable for separating catalytic and non-catalytic roles.

Knock-in

Knock-in of disease-associated mutations (e.g., PPIB mutations in osteogenesis imperfecta) into isogenic cell lines allows study of mutation-specific effects on protein folding and function. Tagged knock-in (e.g., GFP) enables localization and interaction studies.

Overexpression

CRISPR activation (CRISPRa) or cDNA overexpression can model PPIase upregulation observed in cancers. Overexpression models help identify downstream signaling changes and test inhibitors.

How EDITGENE Supports peptidyl-prolyl cis-trans isomerase activity Research

Researchers studying peptidyl-prolyl cis-trans isomerase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell growth, protein folding, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of PPIase genes and their variants.
Contact EDITGENE today to design your custom CRISPR model for peptidyl-prolyl cis-trans isomerase activity research.

Frequently Asked Questions About peptidyl-prolyl cis-trans isomerase activity

It is the enzymatic activity that catalyzes the interconversion between cis and trans conformations of peptide bonds preceding proline residues, as defined by GO:0003755.
Genes include PPIA, PPIB, PPIC, PPID, PPIE, PPIF, PPIG, PPIH, PPIL1, FKBP1A, FKBP5, PIN1, and PIN4, among others [3,4,7].
PPIases are linked to cancer, Alzheimer disease, infectious diseases, and genetic disorders such as osteogenesis imperfecta [1,4,7].
It is commonly measured using chromogenic substrates like N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide in a coupled assay with chymotrypsin.
Pin1 regulates cell cycle and is implicated in cancer and Alzheimer disease through isomerization of phosphorylated Ser/Thr-Pro motifs.
Yes, cyclophilin inhibitors (e.g., cyclosporin A) and FKBP inhibitors (e.g., FK506) are used clinically, and non-immunosuppressive inhibitors are in development.
The three main families are cyclophilins, FK506-binding proteins (FKBPs), and parvulins, each with distinct inhibitor sensitivities.
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional dissection of PPIase genes in disease and development [5,8].
Yes, cell surface PPIase activity has been detected and correlates with extracellular matrix development.
Rotamase is a synonym for peptidyl-prolyl cis-trans isomerase activity, referring to the same catalytic function.

Conclusion

Peptidyl-prolyl cis-trans isomerase activity (GO:0003755) is a critical enzymatic function that controls protein folding and signaling through proline isomerization. Its involvement in cancer, neurodegeneration, and infectious diseases makes it a prime target for therapeutic development [1,7]. Advances in CRISPR-based models and screening technologies are accelerating our understanding of PPIase biology and enabling the discovery of novel inhibitors [3,5,8]. Continued research into this activity will likely yield new insights into disease mechanisms and therapeutic strategies.

References

  1. 1. Steinert M. 2022. Editorial: Peptidyl-prolyl cis/trans isomerases (PPIases) in host-pathogen interactions.. Front Cell Infect Microbiol 12:1097771 PMID: 36569202
  2. 2. Lin W et al.. 2019. Peptidyl prolyl cis/trans isomerase activity on the cell surface correlates with extracellular matrix development.. Commun Biol 2:58 PMID: 30775459
  3. 3. Schiene-Fischer C et al.. 2022. Non-Immunosuppressive Cyclophilin Inhibitors.. Angew Chem Int Ed Engl 61(39):e202201597 PMID: 35290695
  4. 4. Schiene-Fischer C. 2015. Multidomain Peptidyl Prolyl cis/trans Isomerases.. Biochim Biophys Acta 1850(10):2005-16 PMID: 25445709
  5. 5. Kim G et al.. 2015. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.. Biol Pharm Bull 38(7):975-9 PMID: 26133706
  6. 6. Anto NP et al.. 2023. The Peptidyl-Prolyl cis-trans isomerase, Pin1, associates with Protein Kinase C θ via a critical Phospho-Thr-Pro motif in the V3 regulatory domain.. Front Immunol 14:1126464 PMID: 36969236
  7. 7. Lee TH et al.. 2011. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.. Expert Rev Mol Med 13:e21 PMID: 21682951
  8. 8. da Costa KS et al.. 2020. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.. Curr Comput Aided Drug Des 16(5):605-617 PMID: 31654518
Contact Us
*
*
*
*
How did you hear about us: